Dimethylformamide → 3-(3-Bromo-5-iodo-2-thienyl)-1-{[2-(trimethylsilyl)ethoxy]methyl}-1H-1,2,4-triazole

HRID 2401992Notes

Reaction equation

HRID 2401992 reaction equation
[Br:1][C:2]1[CH:6]=[C:5]([I:7])[S:4][C:3]=1[C:8]1[NH:12][CH:11]=[N:10][N:9]=1.C(N(CC)C(C)C)(C)C.CN(C)C=O.[CH3:27][Si:28]([CH3:35])([CH3:34])[CH2:29][CH2:30][O:31][CH2:32]Cl>CCOC(C)=O.O>[Br:1][C:2]1[CH:6]=[C:5]([I:7])[S:4][C:3]=1[C:8]1[N:12]=[CH:11][N:10]([CH2:32][O:31][CH2:30][CH2:29][Si:28]([CH3:35])([CH3:34])[CH3:27])[N:9]=1

Participants

7

Procedure

Into a solution of 3-(3-bromo-5-iodo-2-thienyl)-4H-1,2,4-triazole (500.0 mg, 1.40 mmol), N,N-dimethylaminopyridine (17.2 mg, 0.140 mmol) and N,N-diisopropylethylamine (0.32 mL, 1.83 mmol) in N,N-dimethylformamide (17.0 mL, 220 mmol) was added [β-(Trimethylsilyl)ethoxy]methyl chloride (0.270 mL, 1.55 mmol) was added and the solution was stirred for 2 h at rt. Water (5.0 mL) and EtOAc (5 mL) were added, the organic layer was separated, washed with brine, dried over MgSO4, filtered, concentrated and the obtained residue was purified by column chromatography (SiO2, elution with 0-30% EtOAc in hexane) to give the title compound as a yellowish oil (653 mg, (87% major isomer, 13% minor isomer) LCMS: (FA) ES+, 486, 488. (major isomer)1H NMR (400 MHz, d6-DMSO) δ: 8.81 (s, 1H), 7.45 (s, 1H), 5.540-5.545 (s, br, 2H), 3.62-3.66 (m, 2H), 0.840-0.880 (m, 2H), −0.05 (s, 9H). LCMS: (FA) ES+, 486, 488. (minor isomer) 1H NMR (400 MHz, d6-DMSO) δ: 8.215 (s, 1H), 7.615 (s, 1H), 5.48 (s, br, 2H), 3.44-3.50 (m, 2H), 0.75-0.80 (m, 2H), −0.08 (s, 9H).

Workup

  1. additionwas added
  2. customthe organic layer was separated
  3. washwashed with brine
  4. dry with materialdried over MgSO4
  5. filtrationfiltered
  6. concentrationconcentrated
  7. customthe obtained residue was purified by column chromatography (SiO2, elution with 0-30% EtOAc in hexane)

Sources & evidence

ORD record
ord-487a707a65774a7a99fe97157fe8d0ca
Source dataset
uspto-grants-2014_08
Patent number
US08796271B2

Reaction notes

Loading…